These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 29031688

  • 1. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
    de Sousa Almeida-Filho B, De Luca Vespoli H, Pessoa EC, Machado M, Nahas-Neto J, Nahas EAP.
    J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
    Schmitt EB, Nahas-Neto J, Bueloni-Dias F, Poloni PF, Orsatti CL, Petri Nahas EA.
    Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer.
    Ismail A, El-Awady R, Mohamed G, Hussein M, Ramadan SS.
    Asian Pac J Cancer Prev; 2018 Feb 26; 19(2):571-576. PubMed ID: 29481024
    [Abstract] [Full Text] [Related]

  • 4. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C, Park K, Kim J, Sin Y, Park I, Cho H, Yang K, Bae BN, Kim KW, Ahn S, Gwak G.
    World J Surg Oncol; 2016 Sep 13; 14(1):244. PubMed ID: 27619909
    [Abstract] [Full Text] [Related]

  • 5. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A, Yagi T, Yanai A, Miyagawa Y, Enomoto Y, Murase K, Imamura M, Takatsuka Y, Sakita I, Hatada T, Miyoshi Y.
    Clin Breast Cancer; 2015 Jun 13; 15(3):204-11. PubMed ID: 25600243
    [Abstract] [Full Text] [Related]

  • 6. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Motoki AH, Buttros DAB, Gaspar AL, Almeida-Filho BS, Carvalho-Pessoa E, Vespoli HDL, Nahas-Neto J, Nahas EAP.
    Clin Breast Cancer; 2022 Feb 13; 22(2):e253-e261. PubMed ID: 34465534
    [Abstract] [Full Text] [Related]

  • 7. Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women.
    Machado MRM, de Sousa Almeida-Filho B, De Luca Vespoli H, Schmitt EB, Nahas-Neto J, Nahas EAP.
    Menopause; 2019 Mar 13; 26(3):293-299. PubMed ID: 30234730
    [Abstract] [Full Text] [Related]

  • 8. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.
    Peppone LJ, Rickles AS, Janelsins MC, Insalaco MR, Skinner KA.
    Ann Surg Oncol; 2012 Aug 13; 19(8):2590-9. PubMed ID: 22446898
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer.
    Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH, Gong GY, Kim SB, Ahn SH.
    Ann Surg Oncol; 2011 Jul 13; 18(7):1830-6. PubMed ID: 21573699
    [Abstract] [Full Text] [Related]

  • 10. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
    Ehinger A, Malmström P, Bendahl PO, Elston CW, Falck AK, Forsare C, Grabau D, Rydén L, Stål O, Fernö M, South and South-East Swedish Breast Cancer Groups.
    Acta Oncol; 2017 Jan 13; 56(1):68-74. PubMed ID: 27762648
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer molecular subtypes and receptor status among women at Potchefstroom Hospital: a cross-sectional study.
    Kakudji BK, Mwila PK, Burger JR, du Plessis JM, Naidu K.
    Pan Afr Med J; 2021 Jan 13; 38():85. PubMed ID: 33889251
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H, Ogiya A, Shien T, Horimoto Y, Masuda N, Inao T, Osako T, Takahashi M, Endo Y, Hosoda M, Ishida N, Horii R, Yamazaki K, Miyoshi Y, Yasojima H, Tomioka N, Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
    Breast Cancer; 2016 Nov 13; 23(6):830-843. PubMed ID: 26467036
    [Abstract] [Full Text] [Related]

  • 14. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
    Kinoe H, Yamanouchi K, Kuba S, Morita M, Sakimura C, Kanetaka K, Takatsuki M, Abe K, Yano H, Matsumoto M, Otsubo R, Hayashida N, Nagayasu T, Eguchi S.
    J BUON; 2018 Dec 13; 23(7):60-66. PubMed ID: 30722113
    [Abstract] [Full Text] [Related]

  • 15. Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa.
    Hadgu E, Seifu D, Tigneh W, Bokretsion Y, Bekele A, Abebe M, Sollie T, Merajver SD, Karlsson C, Karlsson MG.
    BMC Womens Health; 2018 Feb 14; 18(1):40. PubMed ID: 29444670
    [Abstract] [Full Text] [Related]

  • 16. Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.
    Kermani IA, Kojidi HT, Gharamaleki JV, Sanaat Z, Ziaei JE, Esfahani A, Seifi S, Ghojazadeh M, Dolatkhah R, Kermani AA, Rad EG.
    Asian Pac J Cancer Prev; 2011 Feb 14; 12(6):1381-4. PubMed ID: 22126468
    [Abstract] [Full Text] [Related]

  • 17. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME, García-Gómez J, Alves MT, Paradela A, García-Mata J, García-Caballero T.
    Clin Transl Oncol; 2016 Oct 14; 18(10):996-1002. PubMed ID: 26742937
    [Abstract] [Full Text] [Related]

  • 18. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
    Streb J, Glanowska I, Streb A, Szpor J, Kryka K, Potocki P, Wójcik M, Jach R.
    Neuro Endocrinol Lett; 2017 Dec 14; 38(6):437-440. PubMed ID: 29298285
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M, Tsuda H, Yoshida M, Shimizu C, Kinoshita T, Tamura K.
    Clin Breast Cancer; 2017 Feb 14; 17(1):41-47. PubMed ID: 27477822
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study.
    Buono G, Giuliano M, De Angelis C, Lauria R, Forestieri V, Pensabene M, Bruzzese D, De Placido S, Arpino G.
    Clin Breast Cancer; 2017 Nov 14; 17(7):559-563. PubMed ID: 28601383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.